BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,572,154 | -19.4% | 200,640 | -2.7% | 0.03% | -15.0% |
| Q2 2023 | $9,393,105 | +11.3% | 206,170 | -0.9% | 0.04% | +5.3% |
| Q1 2023 | $8,441,023 | -21.5% | 208,112 | -1.0% | 0.04% | -26.9% |
| Q4 2022 | $10,747,245 | -8.0% | 210,257 | -3.1% | 0.05% | -11.9% |
| Q3 2022 | $11,685,000 | -16.1% | 216,964 | +0.1% | 0.06% | -9.2% |
| Q2 2022 | $13,920,000 | -18.2% | 216,732 | -1.2% | 0.06% | -1.5% |
| Q1 2022 | $17,017,000 | -13.3% | 219,462 | -2.6% | 0.07% | -2.9% |
| Q4 2021 | $19,632,000 | +5.9% | 225,296 | -2.3% | 0.07% | -4.2% |
| Q3 2021 | $18,547,000 | -3.5% | 230,601 | -3.4% | 0.07% | 0.0% |
| Q2 2021 | $19,211,000 | -6.6% | 238,651 | -2.1% | 0.07% | -13.4% |
| Q1 2021 | $20,569,000 | -0.6% | 243,885 | -5.7% | 0.08% | -3.5% |
| Q4 2020 | $20,697,000 | +2.9% | 258,691 | +3.4% | 0.08% | -7.6% |
| Q3 2020 | $20,121,000 | -9.5% | 250,203 | -3.1% | 0.09% | -15.6% |
| Q2 2020 | $22,238,000 | +9.1% | 258,273 | +2.9% | 0.11% | -8.4% |
| Q1 2020 | $20,376,000 | -4.6% | 250,987 | -1.7% | 0.12% | +24.0% |
| Q4 2019 | $21,357,000 | -5.7% | 255,409 | -1.3% | 0.10% | -11.9% |
| Q3 2019 | $22,641,000 | +6.1% | 258,855 | -0.7% | 0.11% | +3.8% |
| Q2 2019 | $21,346,000 | +8.8% | 260,597 | +8.0% | 0.10% | -0.9% |
| Q1 2019 | $19,614,000 | -64.3% | 241,226 | -71.1% | 0.11% | -19.1% |
| Q4 2018 | $54,876,000 | -14.7% | 833,914 | -0.1% | 0.13% | -0.8% |
| Q3 2018 | $64,318,000 | +5.1% | 834,594 | +0.7% | 0.13% | -1.5% |
| Q2 2018 | $61,196,000 | +21.0% | 828,790 | +6.5% | 0.13% | +17.5% |
| Q1 2018 | $50,594,000 | +3.0% | 777,877 | +2.4% | 0.11% | +5.6% |
| Q4 2017 | $49,124,000 | +2.4% | 759,806 | -0.7% | 0.11% | -4.4% |
| Q3 2017 | $47,995,000 | +3.6% | 765,089 | -0.0% | 0.11% | -4.2% |
| Q2 2017 | $46,318,000 | +14.6% | 765,319 | -1.7% | 0.12% | +11.3% |
| Q1 2017 | $40,410,000 | +4.6% | 778,899 | -10.6% | 0.11% | +7.1% |
| Q4 2016 | $38,618,000 | +378.5% | 871,125 | +406.7% | 0.10% | -17.5% |
| Q3 2016 | $8,071,000 | -2.1% | 171,930 | -6.5% | 0.12% | -3.2% |
| Q2 2016 | $8,243,000 | -33.2% | 183,867 | -38.6% | 0.12% | -31.1% |
| Q1 2016 | $12,345,000 | +3.7% | 299,249 | -3.1% | 0.18% | +1.1% |
| Q4 2015 | $11,906,000 | +35.0% | 308,848 | +14.5% | 0.18% | +32.8% |
| Q3 2015 | $8,818,000 | -47.6% | 269,719 | +13.3% | 0.13% | -42.5% |
| Q2 2015 | $16,819,000 | +6.2% | 238,146 | +3.4% | 0.23% | +18.9% |
| Q1 2015 | $15,835,000 | +230.3% | 230,337 | +256.8% | 0.20% | +216.1% |
| Q4 2014 | $4,794,000 | -16.4% | 64,555 | -19.1% | 0.06% | -21.5% |
| Q3 2014 | $5,736,000 | -0.0% | 79,840 | +1.1% | 0.08% | -8.1% |
| Q2 2014 | $5,738,000 | -2.1% | 78,937 | -1.6% | 0.09% | -6.5% |
| Q1 2014 | $5,860,000 | +10.3% | 80,252 | +5.0% | 0.09% | +12.2% |
| Q4 2013 | $5,312,000 | +1.9% | 76,452 | -2.8% | 0.08% | +5.1% |
| Q3 2013 | $5,211,000 | +13.9% | 78,691 | +19.8% | 0.08% | +5.4% |
| Q2 2013 | $4,577,000 | – | 65,673 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |